Mikio Arisawa
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility 23
- Molecular Biology top 2%
- Fungal and yeast genetics research 27
- Studies on Chitinases and Chitosanases 11
- Plant Science top 2%
- Polysaccharides and Plant Cell Walls 12
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria 11
- Pharmacology top 2%
-
- Biofuel production and bioconversion 11
-
- Neuropeptides and Animal Physiology 9
-
- Enzyme Production and Characterization 8
- Co-authors
- Toshiyuki MioHisafumi Yamada‐OkabeToshiko Yamada‐OkabeKunio KitadaShunsuke InoueTakahide WatanabeKenji HamadaEmi Yamaguchi
- Journals
- Science (1 paper)Proceedings of the National Academy of Sciences (1 paper)Nucleic Acids Research (1 paper)
- Partner nations
- JapanSwitzerlandUnited States
In The Last Decade
Mikio Arisawa
117 papers receiving 5.0k citations
Peers
Comparison fields: 5 of 118
- Infectious Diseases 1.3k
- Molecular Biology 3.5k
- Plant Science 1.3k
- Molecular Medicine 159
- Pharmacology 534
Countries citing papers authored by Mikio Arisawa
This map shows the geographic impact of Mikio Arisawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Arisawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Arisawa more than expected).
Fields of papers citing papers by Mikio Arisawa
This network shows the impact of papers produced by Mikio Arisawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Arisawa. The network helps show where Mikio Arisawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mikio Arisawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 128 | |
| 2 | 2012 | 39 | |
| 3 | 2000 | 22 | |
| 4 | 2000 | 36 | |
| 5 | 2000 | 42 | |
| 6 | 1999 | 96 | |
| 7 | 1999 | 84 | |
| 8 | 1999 | 38 | |
| 9 | 1998 | 2 | |
| 10 | 1998 | 141 | |
| 11 | 1997 | 24 | |
| 12 | Panclicins, novel pancreatic lipase inhibitors. I. Taxonomy, fermentation, isolation and biological activity.:I. TAXONOMY, FERMENTATION, ISOLATION AND BIOLOGICAL ACTIVITY | 1994 | 4 |
| 13 | 1993 | 17 | |
| 14 | 1993 | 12 | |
| 15 | 1992 | 23 | |
| 16 | 1989 | 57 | |
| 17 | 1978 | 7 | |
| 18 | 1978 | 6 | |
| 19 | 1978 | 10 | |
| 20 | 1978 | 3 |
About Mikio Arisawa
Mikio Arisawa is a scholar working on Molecular Medicine, Toxicology and Molecular Biology, having authored 118 papers that have together received 5.2k indexed citations. Recurring topics across this work include Fungal and yeast genetics research (27 papers), Antifungal resistance and susceptibility (23 papers), Polysaccharides and Plant Cell Walls (12 papers), Antibiotic Resistance in Bacteria (11 papers), Studies on Chitinases and Chitosanases (11 papers), Biofuel production and bioconversion (11 papers), Neuropeptides and Animal Physiology (9 papers) and Enzyme Production and Characterization (8 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Molecular Biology (3.5k citations) and Plant Science (1.3k citations). Mikio Arisawa has collaborated with scholars based in Japan, Switzerland and United States. Frequent co-authors include Toshiyuki Mio, Hisafumi Yamada‐Okabe, Toshiko Yamada‐Okabe, Kunio Kitada, Shunsuke Inoue, Takahide Watanabe, Kenji Hamada, Emi Yamaguchi, Tomio Yabe and Masayuki Sudoh. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.